Manufacturers Life Insurance Company, The Solid Biosciences Inc. Transaction History

Manufacturers Life Insurance Company, The

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$3.49 - $5.51 $44,982 - $71,018	-12,889 Closed	0 $0
Q1 2021 May 03, 2021	SELL	$5.37 - $10.72 $32,633 - $65,145	-6,077 Reduced 32.04%	12,889 $71,000
Q4 2020 Feb 12, 2021	BUY	$3.08 - $7.79 $58,415 - $147,745	18,966 New	18,966 $144,000
Q2 2020 Aug 10, 2020	SELL	$2.1 - $3.42 $23,717 - $38,625	-11,294 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$2.31 - $4.43 $26,089 - $50,032	11,294 New	11,294 $27,000
Q4 2019 Feb 14, 2020	SELL	$2.82 - $12.9 $34,609 - $158,321	-12,273 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$4.33 - $11.64 $53,142 - $142,857	12,273 New	12,273 $132,000
Q4 2018 Feb 14, 2019	SELL	$21.32 - $46.34 $99,969 - $217,288	-4,689 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$36.35 - $51.7 $97,854 - $139,176	-2,692 Reduced 36.47%	4,689 $221,000
Q2 2018 Aug 14, 2018	BUY	$7.33 - $43.15 $54,102 - $318,490	7,381 New	7,381 $263,000

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $24.6M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.